Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria

Biomolecules(2023)10.3390/biom14010027Source: DataRank Database

Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria is a research paper published in Biomolecules (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (31)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Sang Mi Lee ORCID,Lin Gan ORCID,Hector A. Bergonia,Robert J. Desnick ORCID,John D. Phillips ORCID

Live enrichment

PubMed:38254627 PMC:PMC10813085

National Institutes of Health (NIH)

Grant: K01 DK087971

National Institutes of Health (NIH)

Grant: U54DK083909

National Institutes of Health (NIH)

Grant: NIH U54DK110858

NIDDK NIH HHS

Grant: U54 DK110858

National Institutes of Health

Grant: 1U54DK083909-01

Porphyria Rare Disease Clinical Research Consortium (RDCRC)

National Institutes of Health

Grant: 3U54DK110858-04S2

Center for Iron and Heme Disorders (CIHD)

National Institutes of Health

Grant: 5K01DK087971-04

Acute Hepatic Porphyrias: Pathogenesis & Treatment

goldLicense: cc-by

publisherhttps://www.mdpi.com/2218-273X/14/1/27/pdf?version=1703414372

publisherhttps://www.mdpi.com/2218-273X/14/1/27/pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10813085/pdf/biomolecules-14-00027.pdf

repositoryhttps://doaj.org/article/b2a9a0093e7c481e8dbbc7536f5301e4

Europe_PMChttps://europepmc.org/articles/PMC10813085

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsMicePorphyria, Acute IntermittentProtoporphyria, ErythropoieticCimetidineAminolevulinic AcidHemeHeme Oxygenase (Decyclizing)Nitric Oxide Synthase

Keywords

Heme oxygenase5-aminolevulinic acid synthaseCimetidineAcute Intermittent PorphyriaErythropoietic ProtoporphyriaPorphyriasDisorders Of Heme BiosynthesisTherapies For PorphyriasProtoporphyria, ErythropoieticAminolevulinic AcidHemeMicrobiologyQR1-502ArticleMicePorphyria, Acute IntermittentHeme Oxygenase (Decyclizing)AnimalsNitric Oxide Synthase

Sustainable Development Goals

SDG 3: 3. Good health

Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria

FAIR Checklist

Authors (6)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)